PapersFlow Research Brief
Blood transfusion and management
Research Guide
What is Blood transfusion and management?
Blood transfusion and management is the clinical practice of administering blood components such as red blood cells, plasma, and platelets to treat anemia, hemorrhage, and related conditions in settings including trauma, cardiac surgery, and critical care, alongside strategies to optimize transfusion thresholds and minimize complications like transfusion-related acute lung injury.
This field encompasses 43,517 papers examining transfusion effects on mortality, morbidity, and complications from anemia and hemorrhage. Studies compare restrictive versus liberal transfusion strategies, with Hébert et al. (1999) demonstrating that a restrictive approach using red-cell transfusions is at least as effective as a liberal strategy in critically ill patients. Research also covers tranexamic acid use and blood product ratios in trauma, such as the 1:1:1 ratio evaluated by Holcomb et al. (2015).
Topic Hierarchy
Research Sub-Topics
Tranexamic Acid in Trauma Hemorrhage
This sub-topic examines the antifibrinolytic effects of tranexamic acid on mortality and transfusion needs in trauma-induced bleeding. Researchers conduct RCTs and meta-analyses on timing, dosing, and subgroup outcomes like head injury.
Restrictive vs Liberal Transfusion Strategies
This sub-topic compares hemoglobin thresholds for red blood cell transfusions in critical care and surgery. Researchers analyze RCTs on outcomes like mortality, organ dysfunction, and cost-effectiveness in ICU patients.
Massive Transfusion Protocols
This sub-topic focuses on balanced ratios of plasma, platelets, and RBCs in hemorrhage resuscitation. Researchers study damage control resuscitation, goal-directed therapy, and survival impacts in trauma and surgical bleeding.
Transfusion-Related Acute Lung Injury
This sub-topic investigates immune-mediated TRALI pathogenesis, risk factors, and prevention via donor screening. Researchers explore antibody-mediated mechanisms, biomarkers, and incidence in critical care settings.
Perioperative Blood Management in Cardiac Surgery
This sub-topic covers anemia correction, antifibrinolytics, and cell salvage to reduce transfusions in cardiac procedures. Researchers evaluate patient blood management bundles and impacts on morbidity and costs.
Why It Matters
Blood transfusion and management directly influences patient survival in high-stakes scenarios like severe trauma and critical care. For instance, Hébert et al. (1999) in "A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care" found that a restrictive transfusion strategy reduced risks compared to liberal transfusion in critically ill patients, potentially lowering mortality except in acute myocardial infarction cases. In trauma, Holcomb et al. (2015) showed in "Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma" that a 1:1:1 ratio of plasma, platelets, and red blood cells did not significantly differ from 1:1:2 in mortality outcomes (clinicaltrials.gov NCT01545232). Borgman et al. (2007) reported in "The Ratio of Blood Products Transfused Affects Mortality in Patients Receiving Massive Transfusions at a Combat Support Hospital" that a high plasma-to-RBC ratio of 1:1.4 improved survival to hospital discharge by reducing hemorrhagic death in combat trauma. Villanueva et al. (2013) demonstrated in "Transfusion Strategies for Acute Upper Gastrointestinal Bleeding" that restrictive strategies improved outcomes in gastrointestinal bleeding (NCT00414713). Vincent (2002) highlighted in "Anemia and Blood Transfusion in Critically Ill Patients" the association between transfusions and diminished organ function.
Reading Guide
Where to Start
"A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care" by Hébert et al. (1999), as it provides the foundational comparison of restrictive versus liberal transfusion strategies in critical care, establishing core principles with 5160 citations.
Key Papers Explained
Hébert et al. (1999) in "A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care" established restrictive transfusion efficacy in critical care, which Vincent (2002) in "Anemia and Blood Transfusion in Critically Ill Patients" expanded by linking transfusions to organ dysfunction. Holcomb et al. (2015) in "Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma" built on ratios from Borgman et al. (2007) in "The Ratio of Blood Products Transfused Affects Mortality in Patients Receiving Massive Transfusions at a Combat Support Hospital," refining trauma protocols. Villanueva et al. (2013) in "Transfusion Strategies for Acute Upper Gastrointestinal Bleeding" applied restrictive strategies to bleeding, connecting to Hébert's work.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current research emphasizes precise blood product ratios in trauma and perioperative settings, with ongoing refinements from trials like Holcomb et al. (2015) and Borgman et al. (2007). No recent preprints or news available, so frontiers remain in subgroup analyses for cardiac surgery and critical care complications like acute lung injury.
Papers at a Glance
Frequently Asked Questions
What is a restrictive transfusion strategy?
A restrictive transfusion strategy involves transfusing red blood cells only when hemoglobin levels drop below a certain threshold, typically lower than in liberal strategies. Hébert et al. (1999) showed in critically ill patients that this approach is at least as effective as liberal transfusion and possibly superior, except in acute myocardial infarction. It aims to minimize transfusion-related complications while maintaining adequate oxygen delivery.
How does tranexamic acid affect blood transfusion in trauma?
Tranexamic acid reduces death, vascular occlusive events, and blood transfusion needs in trauma patients with significant haemorrhage. Williams-Johnson et al. (2010) conducted a randomised, placebo-controlled trial (CRASH-2) demonstrating these benefits. It works by inhibiting fibrinolysis to stabilize clots and control bleeding.
What blood product ratios are used in severe trauma?
In severe trauma requiring massive transfusion, ratios such as 1:1:1 (plasma:platelets:red blood cells) or 1:1:2 are compared. Holcomb et al. (2015) found no significant mortality difference between these in a randomized trial (NCT01545232). Borgman et al. (2007) associated a 1:1.4 plasma-to-RBC ratio with improved survival by decreasing hemorrhagic death.
What are outcomes of transfusion in upper gastrointestinal bleeding?
A restrictive transfusion strategy improves outcomes compared to liberal transfusion in acute upper gastrointestinal bleeding. Villanueva et al. (2013) reported significantly better results with restrictive thresholds in a multicenter trial (NCT00414713). This approach reduces rebleeding and mortality risks.
How common is anemia and transfusion in critical care?
Anemia occurs frequently in critically ill patients, leading to high blood transfusion rates. Vincent (2002) observed associations between transfusions and diminished organ function in a multicenter study. This underscores the need for optimized management to mitigate morbidity.
What role does erythropoietin play in managing anemia?
Recombinant human erythropoietin corrects anemia in end-stage renal disease patients on hemodialysis, reducing transfusion requirements. Eschbach et al. (1987) administered it intravenously three times weekly, increasing hematocrit and improving ferrokinetics. It provides an alternative to repeated transfusions.
Open Research Questions
- ? What are the long-term effects of restrictive versus liberal transfusion strategies on organ function in specific subgroups like cardiac surgery patients?
- ? How do optimal plasma-to-RBC ratios vary between combat and civilian trauma settings for massive transfusions?
- ? What mechanisms underlie transfusion-related acute lung injury, and how can it be prevented in perioperative management?
- ? In which anemia patients does tranexamic acid combined with transfusion yield superior outcomes beyond hemorrhage control?
- ? How does endothelial glycocalyx damage from transfusions influence morbidity in critical care?
Recent Trends
The field includes 43,517 works with no specified 5-year growth rate.
Influential studies like Hébert et al. (1999, 5160 citations) and Williams-Johnson et al. (2010, 3183 citations) continue to shape practice, but no recent preprints or news coverage in the last 12 months indicates steady rather than rapidly accelerating activity.
Research Blood transfusion and management with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Blood transfusion and management with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers